Reply to cinar et al. Comment on "Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874"

被引:0
|
作者
Caruntu, Ana [1 ,2 ]
Caruntu, Constantin [3 ,4 ]
Scheau, Cristian [3 ]
机构
[1] Carol Davila Cent Mil Emergency Hosp, Dept Oral & Maxillofacial Surg, Bucharest 010825, Romania
[2] Titu Maiorescu Univ, Fac Dent Med, Dept Oral & Maxillofacial Surg, Bucharest 031593, Romania
[3] Carol Davila Univ Med & Pharm, Dept Physiol, Bucharest 050474, Romania
[4] NC Paulescu Natl Inst Diabet Nutr & Metab Dis, Dept Dermatol, Bucharest 011233, Romania
来源
MEDICINA-LITHUANIA | 2022年 / 58卷 / 11期
关键词
D O I
10.3390/medicina58111576
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Re: Singh et al.: Vaccine-associated uveitis following COVID-19 vaccination: vaccine adverse event reporting system database analysis Reply
    Singh, Rohan Bir
    Parmar, Uday Pratap Singh
    Kahale, Francesca
    Agarwal, Aniruddha
    Tsui, Edmund
    OPHTHALMOLOGY, 2023, 130 (04) : E18 - E19
  • [42] Comment on Ramos-Rincon et al. Palliative Sedation in COVID-19 End-of-Life Care. Retrospective Cohort Study. Medicina 2021, 57, 873
    Twycross, Robert Geoffrey
    Wong, Aaron Kee Yee
    Vivat, Bella
    MEDICINA-LITHUANIA, 2022, 58 (01):
  • [43] Comment on Hosseini et al. Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis. Nutrients 2022, 14, 2134
    Leong, Trudy D. D.
    Blose, Ntombifuthi
    Mabetha, Denny
    Kredo, Tamara
    NUTRIENTS, 2023, 15 (01)
  • [44] Authors' Reply to Mungmunpuntipantip et al.'s Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands"
    Kant, Agnes
    van Hunsel, Florence
    DRUG SAFETY, 2022, 45 (08) : 925 - 926
  • [45] Authors’ Reply to Mungmunpuntipantip et al.’s Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
    Agnes Kant
    Florence van Hunsel
    Drug Safety, 2022, 45 : 925 - 926
  • [46] Reply to Kersting et al. Comment on "Wunsch et al. The Impact of COVID-19 on the Interrelation of Physical Activity, Screen Time and Health-Related Quality of Life in Children and Adolescents in Germany: Results of the Motorik-Modul Study. Children 2021, 8, 98"
    Wunsch, Kathrin
    Nigg, Carina
    Niessner, Claudia
    Schmidt, Steffen C. E.
    Oriwol, Doris
    Hanssen-Doose, Anke
    Burchartz, Alexander
    Eichsteller, Ana
    Kolb, Simon
    Worth, Annette
    Woll, Alexander
    CHILDREN-BASEL, 2021, 8 (07):
  • [47] Reply to Crimi, C.; Cortegiani, A. Comment on "Liu et al. Application of High-Flow Nasal Cannula in COVID-19: A Narrative Review. Life 2022, 12, 1419"
    Liu, Cheng-Wei
    Cheng, Shih-Lung
    LIFE-BASEL, 2022, 12 (10):
  • [48] Timely Treatment and No Change in Thyroid Cancer Mortality During COVID-19 Pandemic. Reply to Nocini et al. No Impact of COVID-19 Pandemic on Early Mortality for Thyroid Cancer in the US. Comment on "Lee et al. Impact of the COVID-19 Pandemic on Thyroid Cancer Surgery. Curr. Oncol. 2024, 31, 3579-3590"
    Lee, Max L.
    Chen, Michelle M.
    CURRENT ONCOLOGY, 2024, 31 (10) : 6270 - 6271
  • [49] Authors' reply to: Rivera-Lillo et al. comment on: Early rehabilitation in post-acute COVID-19 patients: data from an Italian COVID-19 rehabilitation unit and proposal of a treatment protocol
    Curci, Claudio
    Pisano, Fabrizio
    Negrini, Francesco
    de Sire, Alessandro
    EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 2021, 57 (01) : 172 - 173
  • [50] Reply to Nwosu, C.; Ward, KD Comment on "Alharbi et al. Adoption of Health Mobile Apps during the COVID-19 Lockdown: A Health Belief Model Approach.
    Alharbi, Nouf Sahal
    AlGhanmi, Amany Shlyan
    Fahlevi, Mochammad
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (24)